TCIRG1 and nonpapillary renal cell carcinoma: Our preliminary validation of HPA, TIMER 2.0, UALCAN and other databases suggested that high TCIRG1 expression was associated with poor prognosis in ccRCC patients and verified the correlation between TCIRG1 expression and immune features in ccRCC.